Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kaufman

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
Advances in Therapy|April 28, 2019
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements SustainedPeter Gilling, Neil Barber, Mohamed Bidair, et al.
The Journal of Urology|April 28, 2023
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial ResultsNaeem Bhojani, Mo Bidair, Eugene Kramolowsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2023
Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective AnalysisB R Shank, B Primeaux, E K Yeung, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
BJU International|April 26, 2018
WATER II (80-150 mL) procedural outcomesMihir Desai, Mo Bidair, Naeem Bhojani, et al.
BJU International|February 9, 2019
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trialMihir Desai, Mo Bidair, Kevin C Zorn, et al.
Urology|May 7, 2019
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year ResultsNaeem Bhojani, Mohamed Bidair, Kevin C Zorn, et al.
BJUI Compass|April 27, 2022
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial resultsKevin C Zorn, Mohamed Bidair, Andrew Trainer, et al.
The Canadian Journal of Urology|April 26, 2020
Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year resultsMihir Desai, Mo Bidair, Naeem Bhojani, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Advances in Therapy|April 28, 2019
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements SustainedPeter Gilling, Neil Barber, Mohamed Bidair, et al.
The Journal of Urology|April 28, 2023
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial ResultsNaeem Bhojani, Mo Bidair, Eugene Kramolowsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2023
Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective AnalysisB R Shank, B Primeaux, E K Yeung, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
BJU International|April 26, 2018
WATER II (80-150 mL) procedural outcomesMihir Desai, Mo Bidair, Naeem Bhojani, et al.
BJU International|February 9, 2019
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trialMihir Desai, Mo Bidair, Kevin C Zorn, et al.
Urology|May 7, 2019
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year ResultsNaeem Bhojani, Mohamed Bidair, Kevin C Zorn, et al.
BJUI Compass|April 27, 2022
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial resultsKevin C Zorn, Mohamed Bidair, Andrew Trainer, et al.
The Canadian Journal of Urology|April 26, 2020
Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year resultsMihir Desai, Mo Bidair, Naeem Bhojani, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Pageof 30